Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Clinical trial NCT01266174 · COMPLETED
Trial details
- NCT number
- NCT01266174
- Sponsor
- Amarantus BioScience Holdings, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-09-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.